Browse treatments

…Using the selected circRNAs, we establish predictive models for immunotherapy efficacy using multiple methods and conduct performance verific…

…Background Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of blood cancers, but its effi…

…cer and a leading cause of skin cancer-related mortality. While adoptive immunotherapy has shown promise in melanoma treatment, its efficacy is often …

…Background Adoptive cell therapy (ACT) using tumour-infiltrating lymphocytes (TILs) has shown re…

…Background CAR-T therapy is an effective immunotherapy for hematologic malignancies. How…

…hance T cell trafficking, and improve the anti-tumor effects of TAA-T in vitro.Methods Three IL8sr constructs including the CD34 QBEN…

… allogeneic stem cell transplantation is not available to most. Adoptive T-cell therapy (ACT) is a potent strategy against other refractory cancers. Ho…

…Background Immune checkpoint blockades have emerged as major therapies for patients with lung adenocar…

…ive analysis of samples from 111 melanoma patients treated with anti-PD-1 therapy to quantify PD-1/PD-L1 interactions and to assess their associa…

…or monitoring treatment response in patients with aUC receiving EV/P. Serial ctDNA negativity and early ctDNA clearance or strong de…

…ng ALK-positive NSCLC patients with brain metastases undergoing tyrosine kinase inhibitor (TKI) therapy. Quantitative radiomics (analyzing medical images beyond visual…

…ns These results demonstrate that LAG-3/PD-1 dual blockade with chemotherapy exhibits encouraging efficacy in refractory melanoma, particula…